Survey explores physician views on hepatitis C treatment in pregnant individuals, indicating a need for more safety data and guidelines.
Despite relatively high levels of HCV knowledge, few participants have experience with HCV treatment in pregnancy or would consider such treatment. Further availability of safety evidence and the inclusion of specific recommendations in guidelines could increase uptake of DAAs for pregnant individuals.
No takes yet. Share an insight, caveat, or question.
Kushner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: